MLAEM Stock Overview
Ashler Et Manson engages in the brokerage of real estate loans and insurance loans. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Ashler et Manson SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.60 |
| 52 Week High | €3.20 |
| 52 Week Low | €1.60 |
| Beta | 0.25 |
| 11 Month Change | 0% |
| 3 Month Change | -48.05% |
| 1 Year Change | -50.00% |
| 33 Year Change | -28.57% |
| 5 Year Change | -6.43% |
| Change since IPO | 1.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLAEM | FR Diversified Financial | FR Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.3% |
| 1Y | -50.0% | -4.7% | -4.2% |
Return vs Industry: MLAEM underperformed the French Diversified Financial industry which returned -4.7% over the past year.
Return vs Market: MLAEM underperformed the French Market which returned -4.2% over the past year.
Price Volatility
| MLAEM volatility | |
|---|---|
| MLAEM Average Weekly Movement | 11.1% |
| Diversified Financial Industry Average Movement | 5.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: MLAEM's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: MLAEM's weekly volatility has increased from 6% to 11% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | Aymerick Penicaut | www.ashler-manson.com |
Ashler Et Manson engages in the brokerage of real estate loans and insurance loans. It offers various types of fixed or adjustable rate loans, including amortizable loans, ready in fine loans, bridge loans, and mortgage loans; and life insurance. The company was founded in 2003 and is based in Bordeaux, France.
Ashler et Manson SA Fundamentals Summary
| MLAEM fundamental statistics | |
|---|---|
| Market cap | €5.08m |
| Earnings (TTM) | €24.70k |
| Revenue (TTM) | €540.16k |
205.8x
P/E Ratio9.4x
P/S RatioIs MLAEM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLAEM income statement (TTM) | |
|---|---|
| Revenue | €540.16k |
| Cost of Revenue | €247.50k |
| Gross Profit | €292.66k |
| Other Expenses | €267.97k |
| Earnings | €24.70k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0078 |
| Gross Margin | 54.18% |
| Net Profit Margin | 4.57% |
| Debt/Equity Ratio | 44.8% |
How did MLAEM perform over the long term?
See historical performance and comparison